AstraZeneca PLC

About AstraZeneca PLC (AZN)

Company Description:


AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company operates through two primary segments: BioPharmaceuticals and Oncology.

Founded in 1999 through the merger of the Sweden-based Astra AB and the UK-based Zeneca Group PLC, AstraZeneca is headquartered in Cambridge, United Kingdom.


Main Product(s):


AstraZeneca is known for its diverse portfolio in major disease areas including oncology, respiratory, cardiovascular, renal and metabolic diseases. The company has a significant presence in the development of treatments for various forms of cancer and other serious illnesses.


Short History of AstraZeneca PLC:


  • 1999 – AstraZeneca was formed by the merger of Astra AB and Zeneca Group PLC.
  • Early 2000s – The company focused on developing new products in the areas of cardiovascular, respiratory, oncology, and neuroscience.
  • 2010s – Emphasis shifted towards biologics in its research and development efforts.
  • 2020-2021 – AstraZeneca was instrumental in developing one of the first COVID-19 vaccines during the global pandemic.
  • 2023 – Continued focus on innovation in drug development, particularly in oncology and respiratory diseases.

Key Executives:

NameTitlePayExercisedYear Born
Mr. Pascal Soriot D.V.M., M.B.A.CEO & Executive Director5.98MN/A1959
Dr. Aradhana Sarin M.D.CFO & Executive Director3.42MN/A1975
Ms. Pam P. ChengEVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. BoardN/AN/A1971
Mr. Andrew P. BarnettHead of Investor RelationsN/AN/AN/A
Mr. Jeffrey PottCHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory BoardN/AN/AN/A
Gonzalo VinaHead of Global Media RelationsN/AN/AN/A
Dr. Menelas Pangalos Ph.D.EVP of BioPharmaceuticals R&D and Member of External Sustainability Advisory BoardN/AN/A1967
Dr. Ruud Dobber Ph.D.Executive Vice-President of BioPharmaceuticals Business UnitN/AN/AN/A
Dr. Susan Mary Galbraith M.D., Ph.D.Executive Vice President of Oncology Research & DevelopmentN/AN/A1966
Mr. Leon WangExecutive VP of International & China PresidentN/AN/AN/A

Trade smart with Robert Lindner

Charts and financial information provided by TradingView, a popular charting & trading platform.

Check out even more advanced features or grab charts for your website.